Rockwell Medical Inc. (DE) (RMTI) Peer Comparison

$8.04

$0.09 (1.07%)

As on 10-Sep-2026 16:00EDT

Market cap

$32 Mln

Revenue (TTM)

$69 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Edit

	Rockwell Medical Inc. (DE) (RMTI)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Market cap ($ Mln)	32	16,504	17,747	14,622	12,501
Revenue ($ Mln)	69	2,782	1,054	2,436	1,284
Net Profit ($ Mln)	-5.08	491.50	755.85	860.62	-325.10
Net Margin (%)	-7.33	17.67	71.69	35.33	-25.32
RoE (%)	-14.11	110.09	--	42.98	-57.72
Price to Earnings	--	34.72	20.93	18.56	--
Price-To-Book	0.93	38.18	10.51	7.95	23.94

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Rockwell Medical Inc. (DE) (RMTI)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Operating Revenue	69.39	2,782.29	1,054.37	2,435.92	1,283.94
Cost of Revenue	57.10	1,982.07	103.47	85.67	109.42
Gross Profit	11.70	760.62	588.53	2,236.43	902.26
Operating Expenses	16.81	216.81	841.45	1,378.74	1,497.13
Operating Profit (EBIT)	-4.52	583.40	109.45	971.51	-322.62
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-5.08	598.92	101.11	1,035.47	-325.10
Provision for Tax	0.00	107.42	-654.74	174.84	0.00
Profit after Tax (Net Income)	-5.08	491.50	755.85	860.62	-325.10
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Rockwell Medical Inc. (DE) (RMTI)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Shareholder's Funds	35.09	433.86	1,435.90	1,843.76	523.72
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	10.27	187.89	384.48	288.55	346.72
Current Liabilities	11.17	1,435.43	464.70	361.93	374.20
Total Liabilities	57.15	1,975.47	1,302.02	2,844.42	1,259.59

Assets ($ Mln)

	Rockwell Medical Inc. (DE) (RMTI)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Non-Current Assets	20.17	1,006.90	895.24	1,243.41	45.47
Current Assets	36.36	1,050.29	1,389.84	1,250.82	1,199.18
Total Assets	57.15	1,975.47	1,302.02	2,844.42	1,259.59
Total Debt*	13.93	120.10	449.89	165.93	347.75
Net Current Assets	25.19	-385.14	925.52	888.90	824.98

Cashflow ($ Mln)

	Rockwell Medical Inc. (DE) (RMTI)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Cash From Operating Activities	-0.66	713.22	51.77	884.27	-189.55
Cash Flow from Investing Activities	-8.54	-31.14	-8.15	350.44	32.32
Cash from Financing Activities	4.25	-860.39	34.89	-969.59	255.98
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Rockwell Medical Inc. (DE) (RMTI)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
ROCE (%)	-11.12	53.56	-30.01	32.82	-31.49
ROE (%)	-14.11	110.09	163.18	42.98	-57.72
ROA (%)	-7.75	15.64	31.68	29.32	-22.97
EBIT Margin (%)	-5.69	21.13	5.73	31.04	-18.97
Net Margin (%)	-7.33	17.67	71.69	35.33	-25.32
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Rockwell Medical Inc. (DE) (RMTI)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Revenue Growth (%)	-21.12	24.67	114.85	9.23	149.04
EBIT Growth (%)	-313.61	18.70	136.39	-3.99	9.16
Net Profit Growth (%)	-142.21	17.50	378.76	42.89	-15.32
EPS Growth (%)	-123.34	26.84	353.27	50.42	-0.64
Book Value Growth (%)	0.00	164.02	816.12	-0.70	-42.66

Valuation Ratios

	Rockwell Medical Inc. (DE) (RMTI)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Price / Earnings	-0.62	36.06	-59.76	15.79	-45.32
Price / Book Value	0.09	35.44	-80.42	5.72	21.68
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	4.62	28.08	-121.54	12.44	-47.02
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Rockwell Medical Inc. (DE) (RMTI)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debt to Equity	0.21	0.00	0.27	0.00	0.65
Short term debt to equity ratio	0.10	0.00	0.05	0.00	0.00
Current Ratio	3.25	0.73	2.99	3.46	3.20
Quick Ratio	3.00	0.73	2.32	3.38	2.94
Interest Coverage	-3.48	--	1.62	--	-9.32

Operating Efficiency Ratios

	Rockwell Medical Inc. (DE) (RMTI)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debtors to sales (%)	11.97	15.88	21.25	13.74	14.98
Asset Turnover	1.06	0.89	0.44	0.83	0.91
Receivable days	43.33	50.42	85.52	43.48	35.88
Inventory Days	29.19	--	1,056.70	96.17	354.23
Payable days	15.44	6.26	331.01	147.97	300.79
Cash Conversion Cycle	57.08	--	811.21	-8.32	89.33

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly